Internal Medicine, Pulmonary Disease · Munster, IN
NPI
1013115039
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
4
Medicare group memberships
Hospitals
6
Hospital affiliations
8840 Calumet Ave Ste 203
Munster, IN, 46321
Phone (219) 836-7723
Groups this clinician bills Medicare through
Medicare paid, 2024
$402K
4,470 services
Medicare patients, 2024
765
Average age 74
Drug cost, 2024
$1.6M
5,831 prescriptions
Company payments, 2025
$3,164
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wassim Shwaiki was code 99233 (hospital e&m - subsequent), 2,140 times for 397 patients. In total Wassim Shwaiki billed 4,470 services in 47 codes, and Medicare paid $402K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 2,140 | 397 | $86.83 | $186K |
| 99214 Office E&M - Established | Office | 716 | 336 | $87.83 | $63K |
| 99232 Hospital E&M - Subsequent | Facility | 439 | 174 | $57.42 | $25K |
| 99291 Critical Care E&M | Facility | 358 | 99 | $154.18 | $55K |
| 99223 Hospital E&M - Initial | Facility | 234 | 188 | $126.07 | $29K |
| 99215 Office E&M - Established | Office | 80 | 67 | $129.43 | $10K |
| 99205 Office E&M - New | Office | 50 | 50 | $152.77 | $7,638 |
| 94729 Pulmonary Function Testing | Office | 47 | 42 | $38.84 | $1,826 |
| 95012 Pulmonary | Office | 42 | 38 | $12.75 | $536 |
| 94727 Pulmonary Function Testing | Office | 41 | 37 | $31.16 | $1,278 |
| 94618 Pulmonary Function Testing | Office | 40 | 35 | $22.59 | $903 |
| 94060 Pulmonary Function Testing | Office | 32 | 31 | $27.74 | $888 |
| G0008 Administration of influenza virus vaccine | Office | 16 | 16 | $30.10 | $482 |
| 99292 Critical Care E&M | Facility | 16 | 12 | $78.23 | $1,252 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 15 | 15 | $12.23 | $183 |
By year: 2022 $363K for 4,059 services; 2023 $414K for 4,496 services; 2024 $402K for 4,470 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wassim Shwaiki prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,327 prescriptions and refills. In total Wassim Shwaiki wrote 5,831 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,327 | 1,502 | 364 | $27K |
| Prednisone Generic | 552 | 693 | 215 | $1,755 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 519 | 621 | 123 | $391K |
| Breo Ellipta Fluticasone/Vilanterol | 324 | 395 | 62 | $153K |
| Montelukast Sodium Generic | 261 | 679 | 89 | $2,235 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 184 | 214 | 42 | $131K |
| Fluticasone Propionate Generic | 174 | 329 | 76 | $1,776 |
| Doxycycline Hyclate Generic | 173 | 173 | 121 | $847 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 140 | 165 | 47 | $16K |
| Ventolin Hfa Albuterol Sulfate | 137 | 154 | 47 | $8,790 |
| Spiriva Respimat Tiotropium Bromide | 119 | 141 | 37 | $73K |
| Incruse Ellipta Umeclidinium Bromide | 109 | 127 | 21 | $44K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 107 | 162 | 39 | $11K |
| Furosemide Generic | 102 | 169 | 40 | $324 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 96 | 156 | 24 | $70K |
Brand drugs: 3,163 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wassim Shwaiki $3,164 ($3,164 in general payments such as food, travel and fees) from 26 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $695.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 26 | $695 |
| GlaxoSmithKline, LLC. GSK | 30 | $386 |
| Inspire Medical Systems, Inc. INSP | 5 | $286 |
| Viatris Specialty LLC | 13 | $276 |
| Intuitive Surgical, Inc. ISRG | 2 | $240 |
| Amgen Inc. AMGN | 7 | $149 |
| Insmed, Inc. INSM | 6 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $116 |
| Shionogi Inc 4507.T | 5 | $116 |
| Baxter Healthcare BAX | 6 | $111 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.